Vivo Capital, LLC - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 85 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q3 2021$3,049,000
-47.6%
1,325,7360.0%0.14%
-45.6%
Q2 2021$5,820,000
-39.5%
1,325,7360.0%0.25%
-25.4%
Q1 2021$9,625,000
+68.1%
1,325,7360.0%0.34%
+32.0%
Q4 2020$5,727,000
+5.1%
1,325,7360.0%0.26%
-18.7%
Q3 2020$5,449,000
-31.5%
1,325,7360.0%0.32%
-44.7%
Q2 2020$7,954,000
-35.1%
1,325,736
-18.5%
0.57%
-48.6%
Q1 2020$12,253,000
-33.2%
1,627,225
+24.0%
1.11%
-35.5%
Q2 2019$18,356,000
+113.2%
1,312,084
+172.4%
1.72%
+100.2%
Q1 2019$8,611,000
-32.6%
481,609
-40.7%
0.86%
-47.3%
Q4 2018$12,771,000811,8941.63%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 5,307,751$3,101,0001.18%
TANG CAPITAL MANAGEMENT LLC 2,000,000$1,168,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$4,060,0000.08%
Artal Group S.A. 1,803,858$1,054,0000.06%
GSA CAPITAL PARTNERS LLP 616,402$360,0000.05%
RA Capital Management 3,040,885$1,776,0000.05%
Forefront Analytics, LLC 92,641$58,0000.03%
Temasek Holdings (Private) Ltd 4,319,049$2,523,1880.01%
FEDERATED HERMES, INC. 8,309,859$4,853,0000.01%
Cormorant Asset Management, LP 256,649$150,0000.01%
View complete list of ORCHARD THERAPEUTICS PLC shareholders